Cherenkov luminescence imaging

Cherenkov luminescence imaging (CLI) is an emerging imaging modality, similar to bioluminescence imaging, that captures visible photons emitted by Cherenkov radiation. It basically is the optical imaging of radiotracers that emit charged particles traveling faster than the phase velocity of light in that particular medium. It can be used to quickly evaluate radio tracers in preclinical research [1] but also to obtain clinical images in patients.[2] While radioactivity itself can not be modified the emitted light provides an opportunity to generate radioactivity-based activatable or "smart" imaging agents that sense for example enzymatic activity.[3]

References

  1. ↑ Ruggiero, A; Holland, J. P.; Lewis, J. S.; Grimm, J (2010). "Cerenkov luminescence imaging of medical isotopes". Journal of Nuclear Medicine. 51 (7): 1123–1130. doi:10.2967/jnumed.110.076521. PMC 3068779Freely accessible.
  2. ↑ Thorek, D. L.; Riedl, C. C.; Grimm, J (2013). "Clinical Cerenkov Luminescence Imaging of 18F-FDG". Journal of Nuclear Medicine. 55 (1): 95–98. doi:10.2967/jnumed.113.127266. PMC 3903390Freely accessible.
  3. ↑ Thorek, Daniel L J; Ogirala, Anuja; Beattie, Bradley J; Grimm, Jan (2013). "Quantitative imaging of disease signatures through radioactive decay signal conversion". Nature Medicine. 19 (10): 1345. doi:10.1038/nm.3323. PMID 24013701.
  • Mitchell, G. S.; Gill, R. K.; Boucher, D. L.; Cherry, S. R. (2011). "In vivo Cerenkov luminescence imaging: a new tool for molecular imaging". Physical Transactions of the Royal Society A. 369 (1955): 4605. Bibcode:2011RSPTA.369.4605M. doi:10.1098/rsta.2011.0271. 


This article is issued from Wikipedia - version of the 11/7/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.